Newsfeeds Archive - Page 2 of 7

2 minute read

FSD Pharma Signs Agreement With iNGENu CRO To Conduct A Clinical Study To Assess The Safety And Pharmacokinetics Of Multiple Ascending Doses Of Lucid-21-302 In Healthy Adults

March 27, 8:12 AM

FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma" or the "Company"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting

CSE:HUGE

2 minute read

Legal
News

Safety Shot Responds To FSD Pharma’s Unauthorized Tagging Of Its Stock And Making False Claims In An Effort To Harm The Company And Its Shareholders

By Benzinga Newsdesk

January 17, 9:11 AM

Safety Shot is Not GBB Drink Lab, Inc. (GBB) and never acquired GBB as falsely claimed by FSD Pharma; Only the Safety Shot beverage asset was acquired; The lawsuit referred to by FSD Pharma is with GBB only GBB

HUGE

2 minute read

Legal
News

GBB Drink Lab. Inc Announce That A Federal Court Has Refused To Dismiss The Company’s Ongoing Lawsuit Against FSD Pharma

By Benzinga Newsdesk

January 11, 2:17 PM

GBB Drink Lab. Inc ("GBB" or the "Company"), a maker of the world's first rapid blood alcohol detoxification beverage, is pleased to announce that a federal court has refused to dismiss the Company's ongoing lawsuit

HUGE

5 minute read

Psyched: Biden Approves Psychedelics Trials, RFK, Australia’s First Legal Dedicated Clinic & More

By Lara Goldstein

December 27, 11:09 AM

President Biden Approves Psychedelics Clinical Trials For Active Military Members President Biden signed into law the 2024 National Defense Authorization Act (NDAA), large-scale legislation that also contains a mandate to fund clinical trials with psychedelics for active service members.

ATAI

3 minute read

Inebriation Remedy And Breakthrough MS Treatment: Meet FSD Pharma

By Lara Goldstein

December 21, 11:19 PM

Among a biotech space bursting with innovation, one company stands out as it is developing two assets at once: a ready-for-market drink that can take someone from a drinking state to mental and physical composure in record time and a potential breakthrough therapy for Multiple Sclerosis. Meet FSD Pharma (NASDAQ:

HUGE